— Know what they know.
/
Not Investment Advice

SWTX NASDAQ

SpringWorks Therapeutics, Inc.
1W: +0.0% 1M: +0.7% 3M: +12.2% 1Y: +24.7% 3Y: +76.1% 5Y: +5.5%
$46.99
Last traded 2025-07-02 — delisted
NASDAQ · Healthcare · Biotechnology · $3.5B mcap · 73M float · 7.70% daily turnover · Short 29% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2021-12-15
Earliest Filing
2021-12-15
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named SWTX in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
ALLO Allogene Therapeutics, Inc. partner Partner for investigational gamma secretase inhibitor nirogacestat 2021-12-15 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms